Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.11
Oct 30 • 3:59 PM ET Dollar change-0.06 Percentage change(-5.13%)
Aftermarket Close
1.11
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
39.88M
Enterprise Value
164.95M
Income
5.86M
Sales
183.53M
Book/sh
-2.38
Cash/sh
0.31
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
223
IPO
Apr 28, 2021
P/E
9.22
Forward P/E
4.67
PEG
-
P/S
0.22
P/B
-
P/C
3.57
P/FCF
2.01
EV/EBITDA
6.36
EV/Sales
0.90
Quick Ratio
0.81
Current Ratio
1.43
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
0.12
EPS next Y
0.24
EPS next Q
-0.01
EPS this Y
-96.28%
EPS next Y
763.64%
EPS next 5Y
-12.25%
EPS past 3/5Y
- 11.37%
Sales past 3/5Y
5.23% 10.52%
EPS Y/Y TTM
-82.99%
Sales Y/Y TTM
-7.81%
EPS Q/Q
-328.61%
Sales Q/Q
-9.48%
Insider Own
18.76%
Insider Trans
2.00%
Inst Own
61.97%
Inst Trans
-9.26%
ROA
5.67%
ROE
-
ROIC
9.92%
Gross Margin
66.93%
Oper. Margin
12.03%
Profit Margin
3.19%
SMA20
-0.43%
SMA50
-14.25%
SMA200
-39.28%
Trades
Shs Outstand
27.66M
Shs Float
23.30M
52W High
2.98 -62.75%
52W Low
1.00 11.00%
Volatility
9.95% 9.49%
ATR (14)
0.10
RSI (14)
43.56
Beta
1.73
Rel Volume
0.32
Avg Volume
203.77K
Volume
65,593
Perf Week
3.74%
Perf Month
-4.31%
Perf Quarter
-51.53%
Perf Half Y
-49.32%
Perf YTD
-57.31%
Perf Year
-60.07%
Perf 3Y
-78.78%
Perf 5Y
-88.62%
Perf 10Y
-
Prev Close
1.17
Price
1.11
Change %
-5.13%
Consensus
Buy
Avg. Price Target
$2.61
Implied Upside
+135.1%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 07, 2025Downgrade
RILY logoRB. Riley Securities
Buy → Neutral$4+260.4%
Dec 16, 2024Initiated
CCraig Hallum
Buy
Feb 20, 2024Initiated
RILY logoRB. Riley Securities
Buy$9+710.8%
Feb 01, 2024Initiated
JEF logoJJefferies
Buy
Jun 24, 2022Initiated
CCowen
Outperform$11+891.0%
Jun 23, 2022Initiated
RROTH Capital
Buy$9+710.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beer Marc DExecutive ChairmanAug 10 '26Buy1.53115,950177,404223,744Aug 12 04:25 PM
Beer Marc DExecutive ChairmanAug 11 '26Buy1.5516,00024,800239,744Aug 12 04:25 PM
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
Executive ChairmanMr. Marc D. Beer
Interim CEOMr. Robert C. Peterson
Chief Information OfficerMr. John J. Olsen
General CounselMr. Dan Monico
Chief Digital OfficerMr. Richard Kevin Key